WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · HB 2317

Legislative bill overview

HB 2317 expands the Hawaii Department of Health's regulatory authority over food, drugs, and cosmetics. The bill is currently in early legislative stages, having passed first reading and been referred to the Health (HLT) and Consumer Protection (CPC) committees. Specific provisions are not detailed in the available action history, so the exact scope of expanded authority remains to be defined in committee.

Why is this important

Food, drug, and cosmetic regulation directly affects consumer safety and public health across Hawaii. Clarifying or expanding the Department of Health's authority can improve enforcement capabilities, close regulatory gaps, or streamline inspection processes—but could also increase compliance costs for businesses or alter market access for products currently unregulated at the state level.

Potential points of contention

  • Scope of expanded authority: Unclear whether expansion targets specific product categories (e.g., dietary supplements, imported goods) or broadly increases enforcement powers
  • Business compliance costs: Manufacturers and retailers may face new licensing, labeling, or testing requirements that increase operational expenses
  • Regulatory overlap: Potential duplication or conflict with existing federal FDA regulations, requiring clarification of state versus federal jurisdiction

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.